Clinical Trials
3 trialsNCT07130916 2025-08-19
A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT05430386 2023-02-14
Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT05223595 2022-02-04
A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1 Unknown